News Janssen/AbbVie drug approved in graft-versus-host disease First use for Imbruvica outside blood cancer.
News Takeda begins new R&D link-up with Molecular Templates Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates.
News NICE recommends Celgene pancreatic cancer drug Abraxane finally gets NHS funding following price cut.
News BMS snaps up cancer biotech IFM in $2.3bn deal BMS will gain rights to preclinical cancer immunotherapy drugs.
News Ex-Google exec Jeff Huber steps down as GRAIL CEO Huber takes on new role as vice chairman of Board of Directors.
News Scottish firm gets EU funding for 'off the shelf' cancer cel... First patients could be treated in 2019.
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
